دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair
Angela M. Lowenstern, MD, a, * Andrew M. Vekstein, MD,b,c, * Maria Grau-Sepulveda, MS, c Vinay Badhwar, MD, d Vinod H. Thourani, MD,e David J. Cohen, MD,f,g Paul Sorajja, MD,h Kashish Goel, MD, a Colin M. Barker, MD,a Brian R. Lindman, MD, MS C,a Donald G. Glower, MD,b Andrew Wang, MD, i Sreekanth Vemulapalli, MD
doi : 10.1016/j.jacc.2022.11.043
Volume 81, Issue 6, 14 February 2023, Pages 521-532
TEER Programs at Mitral Surgery Centers: When One Hand Washes the Other∗
Matthew W. Sherwood, MD, MHS, a,b Wayne B. Batchelor, MD, MHS
doi : 10.1016/j.jacc.2022.12.004
Volume 81, Issue 6, 14 February 2023, Pages 533-536
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, MD, PH D, a Roxana Mehran, MD, b Mattia Branca, P HD, c Anna Franzone, MD, PHD, d Usman Baber, MD, MS,e Yangsoo Jang, MD, P HD, f Takeshi Kimura, MD, P HD, g Joo-Yong Hahn, MD, P HD, h Qiang Zhao, MD,i Stephan Windecker, MD,j Charles M. Gibson, MD,k Byeong-Keuk Kim, MD, P HD, f Hirotoshi Watanabe, MD, g Young Bin Song, MD, h Yunpeng Zhu, MD, i Pascal Vranckx, MD, PH D, l,m Shamir Mehta, MD, MS C, n,o Sung-Jin Hong, MD,f Kenji Ando, MD,p Hyeon-Cheol Gwon, MD, h Paolo Calabrò, MD, P HD, a Patrick W. Serruys, MD, P HD, q,r George D. Dangas, MD, P HD, b Eùgene P. McFadden, MD, s,t Dominick J. Angiolillo, MD, PHD, u Dik Heg, PH D, c Marco Valgimigli, MD, PHD, j,v on behalf of the Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration
doi : 10.1016/j.jacc.2022.11.041
Volume 81, Issue 6, 14 February 2023, Pages 537-552
Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?∗
Deepak L. Bhatt, MD, MPH
doi : 10.1016/j.jacc.2022.11.040
Volume 81, Issue 6, 14 February 2023, Pages 553-556
Acute Cardiac Events During COVID-19-Associated Hospitalizations
Rebecca C. Woodruff, PH D, MPH,a,b Shikha Garg, MD, MPH, a,c Mary G. George, MD,a,b Kadam Patel, MBBS, MPH, a,d Sandra L. Jackson, P HD, b Fleetwood Loustalot, P HD, b,c Jonathan M. Wortham, MD,a,c Christopher A. Taylor, PHD, a Michael Whitaker, MPH, a Arthur Reingold, MD, e,f Nisha B. Alden, MPH,g James Meek, MPH,h Evan J. Anderson, MD,i,j,k Andy Weigel, MSW, l Justin Henderson, MPH,m Erica Bye, MPH,n Sarah Shrum Davis, MA, MPH,o Grant Barney, MPH,p Nancy M. Bennett, MD, MS, q Eli Shiltz, MPH,r Melissa Sutton, MD, MPH,s H. Keipp Talbot, MD, MPH,t Andrea Price, LPN, u Laurence S. Sperling, MD, b Fiona P. Havers, MD, MHS, a,c for the COVID-19-Associated Hospitalization Surveillance Network*
doi : 10.1016/j.jacc.2022.11.044
Volume 81, Issue 6, 14 February 2023, Pages 557-569
The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults.
Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease∗
George A. Mensah, MD,a Muthiah Vaduganathan, MD, MPH, b Gregory A. Roth, MD, MPH
doi : 10.1016/j.jacc.2022.11.042
Volume 81, Issue 6, 14 February 2023, Pages 570-573
Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists
Garima Sharma, MD, a,b Shiavax J. Rao, MD, c Pamela S. Douglas, MD, d Anne Rzeszut, MA, e Dipti Itchhaporia, MD, f Malissa J. Wood, MD,g Khurram Nasir, MD, MPH, h Roger S. Blumenthal, MD, a Athena Poppas, MD, i Jeffrey Kuvin, MD, j Andrew P. Miller, MD, k Roxana Mehran, MD,l Michael Valentine, MD,m Richard F. Summers, MD, n Laxmi S. Mehta, MD
doi : 10.1016/j.jacc.2022.11.025
Volume 81, Issue 6, 14 February 2023, Pages 574-586
Mental illness among physicians is an increasingly recognized concern. Global data on mental health conditions (MHCs) among cardiologists are limited.
Mental Health Conditions Among Cardiologists: Silent Suffering∗
Andrew J. Sauer, MD
doi : 10.1016/j.jacc.2022.11.026
Volume 81, Issue 6, 14 February 2023, Pages 587-589
Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review
Alexander G. Truesdell, MD, a,b Mirvat A. Alasnag, MD, c Prashant Kaul, MD,d Syed Tanveer Rab, MD,e Robert F. Riley, MD, f Michael N. Young, MD,g Wayne B. Batchelor, MD,b Akiko Maehara, MD,h Frederick G. Welt, MD,i Ajay J. Kirtane, MD, SM, h,j on behalf of the ACC Interventional Council
doi : 10.1016/j.jacc.2022.11.045
Volume 81, Issue 6, 14 February 2023, Pages 590-605
Coronary angiography has historically served as the gold standard for diagnosis of coronary artery disease and guidance of percutaneous coronary intervention (PCI). Adjunctive use of contemporary intravascular imaging (IVI) technologies has emerged as a complement to conventional angiography—to further characterize plaque morphology and optimize the performance of PCI.
Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week
Gianluigi Bisleri, MD, a,b, * Arjun K. Pandey, BS C, c Subodh Verma, MD, P HD, a,b Syed M. Ali Hassan, MD, a Bobby Yanagawa, MD, P HD, a,b Masud Khandaker, MD, PH D, d Mario Gaudino, MD, P HD, e Andrea M. Russo, MD, f Atul Verma, MD,g Deepak L. Bhatt, MD, MPH,h Andrew C.T. Ha, MD, MS C a,i, *
doi : 10.1016/j.jacc.2022.11.039
Volume 81, Issue 6, 14 February 2023, Pages 606-619
Hybrid ablation is a novel therapy in the invasive management of patients with atrial fibrillation (AF) which combines minimally invasive surgical and percutaneous catheter-based techniques.
Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income Countries
JingJing Z. Zhu, BA Jennifer Manne-Goehler, MD Anubha Agarwal, MD, MSc Silver K. Bahendeka, MD, PhD Albertino Damasceno, PhD Maja E. Marcus, MA Sahar Saeedi Moghaddam, MSc Sebastian Vollmer, PhD Mark D. Huffman, MD, MPH *David Flood, MD, MSc
doi : 10.1016/j.jacc.2022.12.003
Volume 81, Issue 6, 14 February 2023, Pages 620-622
Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair
Angela M. Lowenstern, MD, a, * Andrew M. Vekstein, MD,b,c, * Maria Grau-Sepulveda, MS, c Vinay Badhwar, MD, d Vinod H. Thourani, MD,e David J. Cohen, MD,f,g Paul Sorajja, MD,h Kashish Goel, MD, a Colin M. Barker, MD,a Brian R. Lindman, MD, MS C,a Donald G. Glower, MD,b Andrew Wang, MD, i Sreekanth Vemulapalli, MD
doi : 10.1016/j.jacc.2022.11.043
Volume 81, Issue 6, 14 February 2023, Pages 521-532
TEER Programs at Mitral Surgery Centers: When One Hand Washes the Other∗
Matthew W. Sherwood, MD, MHS, a,b Wayne B. Batchelor, MD, MHS
doi : 10.1016/j.jacc.2022.12.004
Volume 81, Issue 6, 14 February 2023, Pages 533-536
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions
Felice Gragnano, MD, PH D, a Roxana Mehran, MD, b Mattia Branca, P HD, c Anna Franzone, MD, PHD, d Usman Baber, MD, MS,e Yangsoo Jang, MD, P HD, f Takeshi Kimura, MD, P HD, g Joo-Yong Hahn, MD, P HD, h Qiang Zhao, MD,i Stephan Windecker, MD,j Charles M. Gibson, MD,k Byeong-Keuk Kim, MD, P HD, f Hirotoshi Watanabe, MD, g Young Bin Song, MD, h Yunpeng Zhu, MD, i Pascal Vranckx, MD, PH D, l,m Shamir Mehta, MD, MS C, n,o Sung-Jin Hong, MD,f Kenji Ando, MD,p Hyeon-Cheol Gwon, MD, h Paolo Calabrò, MD, P HD, a Patrick W. Serruys, MD, P HD, q,r George D. Dangas, MD, P HD, b Eùgene P. McFadden, MD, s,t Dominick J. Angiolillo, MD, PHD, u Dik Heg, PH D, c Marco Valgimigli, MD, PHD, j,v on behalf of the Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration
doi : 10.1016/j.jacc.2022.11.041
Volume 81, Issue 6, 14 February 2023, Pages 537-552
Optimal Antiplatelet Therapy Revisited: When Is a Single Better Than a Double?∗
Deepak L. Bhatt, MD, MPH
doi : 10.1016/j.jacc.2022.11.040
Volume 81, Issue 6, 14 February 2023, Pages 553-556
Acute Cardiac Events During COVID-19-Associated Hospitalizations
Rebecca C. Woodruff, PH D, MPH,a,b Shikha Garg, MD, MPH, a,c Mary G. George, MD,a,b Kadam Patel, MBBS, MPH, a,d Sandra L. Jackson, P HD, b Fleetwood Loustalot, P HD, b,c Jonathan M. Wortham, MD,a,c Christopher A. Taylor, PHD, a Michael Whitaker, MPH, a Arthur Reingold, MD, e,f Nisha B. Alden, MPH,g James Meek, MPH,h Evan J. Anderson, MD,i,j,k Andy Weigel, MSW, l Justin Henderson, MPH,m Erica Bye, MPH,n Sarah Shrum Davis, MA, MPH,o Grant Barney, MPH,p Nancy M. Bennett, MD, MS, q Eli Shiltz, MPH,r Melissa Sutton, MD, MPH,s H. Keipp Talbot, MD, MPH,t Andrea Price, LPN, u Laurence S. Sperling, MD, b Fiona P. Havers, MD, MHS, a,c for the COVID-19-Associated Hospitalization Surveillance Network*
doi : 10.1016/j.jacc.2022.11.044
Volume 81, Issue 6, 14 February 2023, Pages 557-569
The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults.
Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease∗
George A. Mensah, MD,a Muthiah Vaduganathan, MD, MPH, b Gregory A. Roth, MD, MPH
doi : 10.1016/j.jacc.2022.11.042
Volume 81, Issue 6, 14 February 2023, Pages 570-573
Prevalence and Professional Impact of Mental Health Conditions Among Cardiologists
Garima Sharma, MD, a,b Shiavax J. Rao, MD, c Pamela S. Douglas, MD, d Anne Rzeszut, MA, e Dipti Itchhaporia, MD, f Malissa J. Wood, MD,g Khurram Nasir, MD, MPH, h Roger S. Blumenthal, MD, a Athena Poppas, MD, i Jeffrey Kuvin, MD, j Andrew P. Miller, MD, k Roxana Mehran, MD,l Michael Valentine, MD,m Richard F. Summers, MD, n Laxmi S. Mehta, MD
doi : 10.1016/j.jacc.2022.11.025
Volume 81, Issue 6, 14 February 2023, Pages 574-586
Mental illness among physicians is an increasingly recognized concern. Global data on mental health conditions (MHCs) among cardiologists are limited.
Mental Health Conditions Among Cardiologists: Silent Suffering∗
Andrew J. Sauer, MD
doi : 10.1016/j.jacc.2022.11.026
Volume 81, Issue 6, 14 February 2023, Pages 587-589
Intravascular Imaging During Percutaneous Coronary Intervention: JACC State-of-the-Art Review
Alexander G. Truesdell, MD, a,b Mirvat A. Alasnag, MD, c Prashant Kaul, MD,d Syed Tanveer Rab, MD,e Robert F. Riley, MD, f Michael N. Young, MD,g Wayne B. Batchelor, MD,b Akiko Maehara, MD,h Frederick G. Welt, MD,i Ajay J. Kirtane, MD, SM, h,j on behalf of the ACC Interventional Council
doi : 10.1016/j.jacc.2022.11.045
Volume 81, Issue 6, 14 February 2023, Pages 590-605
Coronary angiography has historically served as the gold standard for diagnosis of coronary artery disease and guidance of percutaneous coronary intervention (PCI). Adjunctive use of contemporary intravascular imaging (IVI) technologies has emerged as a complement to conventional angiography—to further characterize plaque morphology and optimize the performance of PCI.
Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week
Gianluigi Bisleri, MD, a,b, * Arjun K. Pandey, BS C, c Subodh Verma, MD, P HD, a,b Syed M. Ali Hassan, MD, a Bobby Yanagawa, MD, P HD, a,b Masud Khandaker, MD, PH D, d Mario Gaudino, MD, P HD, e Andrea M. Russo, MD, f Atul Verma, MD,g Deepak L. Bhatt, MD, MPH,h Andrew C.T. Ha, MD, MS C a,i, *
doi : 10.1016/j.jacc.2022.11.039
Volume 81, Issue 6, 14 February 2023, Pages 606-619
Hybrid ablation is a novel therapy in the invasive management of patients with atrial fibrillation (AF) which combines minimally invasive surgical and percutaneous catheter-based techniques.
Medication Use for Cardiovascular Disease Prevention in 40 Low- and Middle-Income Countries
JingJing Z. Zhu, BA Jennifer Manne-Goehler, MD Anubha Agarwal, MD, MSc Silver K. Bahendeka, MD, PhD Albertino Damasceno, PhD Maja E. Marcus, MA Sahar Saeedi Moghaddam, MSc Sebastian Vollmer, PhD Mark D. Huffman, MD, MPH *David Flood, MD, MSc
doi : 10.1016/j.jacc.2022.12.003
Volume 81, Issue 6, 14 February 2023, Pages 620-622
